Pfizer buys Baxter's vaccine business

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE -1.7%) enters into a definitive agreement to acquire Baxter International's (BAX +0.7%) vaccine business for $635M. The transaction includes a portion of Baxter's manufacturing facility in Orth, Austria.

The deal is expected to close by the end of 2014. Pfizer says that it will not impact its guidance for the year.